Foundation Medicine
Speed Read
0%
300 WPM
-- remaining
Molecular profiling company providing comprehensive genomic testing to guide cancer treatment decisions, acquired by Roche.
Biology of Business
Molecular profiling company providing comprehensive genomic testing to guide cancer treatment decisions, acquired by Roche.